ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023)
ENDRA Life Sciences (NDRA) posted quarterly Short term Debt of $28484.0 for Q4 2023, little changed year-over-year from $28484.0 in Q4 2022, and little changed quarter-over-quarter from $28484.0 in Q3 2023.
ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Short term Debt for 2 consecutive years, with $28484.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Short term Debt changed 0.0% year-over-year to $28484.0; the TTM figure through Dec 2023 stood at $28484.0 (changed 0.0% YoY), while the FY2023 annual figure was $28484.0, changed 0.0% from the prior year.
- Short term Debt steadied at $28484.0 in Q4 2023 per NDRA's latest filing, from $28484.0 in the prior quarter.
- Across five years, Short term Debt topped out at $28484.0 in Q4 2022 and bottomed at $28484.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28,484.00 |
| Sep 30, 2023 | 28,484.00 |
| Jun 30, 2023 | 28,484.00 |
| Dec 31, 2022 | 28,484.00 |